Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration
Authors:ID Mountzios, Giannis (Author)
ID Remon, J. (Author)
ID Novello, Silvia (Author)
ID Blais, N. (Author)
ID Califano, R. (Author)
ID Čufer, Tanja (Author)
ID Dingemans, Anne-Marie C. (Author)
ID Liu, S. V. (Author)
ID Peled, N. (Author)
ID Pennell, N. A. (Author)
Files:.pdf PDF - Presentation file, download (106,29 KB)
MD5: 0E9697A221FB531E45F7409FE050F7AE
 
URL URL - Source URL, visit https://academic.oup.com/annonc/article-abstract/30/11/1686/5559466?redirectedFrom=fulltext
 
Language:English
Typology:1.03 - Other scientific articles
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Keywords:non-small cell lung carcinoma, drug therapy, KEYNOTE-024 trial, pemrolizumab, treatment
Publication status:Published
Publication version:Version of Record
Place of publishing:Velika Britanija
Publisher:Elsevier
Year of publishing:2019
Number of pages:str. 1686-1688
Numbering:Vol. 30, iss. 11
PID:20.500.12556/DiRROS-12422 New window
UDC:616.2
ISSN on article:1569-8041
DOI:10.1093/annonc/mdz295 New window
COBISS.SI-ID:2048615281 New window
Copyright:© 2019 THE AUTHORS
Note:Nasl. z nasl. zaslona; Soavtorica iz Slovenije: T. Cufer; Opis vira z dne 15. 1. 2020;
Publication date in DiRROS:21.09.2020
Views:1755
Downloads:1162
Metadata:XML DC-XML DC-RDF
:
MOUNTZIOS, Giannis, REMON, J., NOVELLO, Silvia, BLAIS, N., CALIFANO, R., ČUFER, Tanja, DINGEMANS, Anne-Marie C., LIU, S. V., PELED, N. and PENNELL, N. A., 2019, Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration. Annals of oncology [online]. 2019. Vol. 30, no. 11, p. 1686–1688. [Accessed 24 March 2025]. DOI 10.1093/annonc/mdz295. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=12422
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Annals of oncology
Publisher:Elsevier
ISSN:1569-8041
COBISS.SI-ID:3151892 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Licensing start date:03.09.2019

Secondary language

Language:Undetermined
Keywords:nedrobnocelični karcinom pljuč, terapija z zdravili, raziskava KEYNOTE-024, pemrolizumab, zdravljenje


Archive

niGradiv

Back